Floatz logo

Cytarabine

High Grade B-Cell Lymphoma

University of California, DavisSmall moleculePhase 2Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

84 Active assets in the High Grade B-Cell Lymphoma cohort.

Asset / SponsorPhaseRating
Etoposide
University of Washington
Phase 3BB
Isocyclophosphamide
University of California, Davis
Phase 3BB
Vincristine Sulfate
National Cancer Institute (NCI)
Phase 2/3BB
Prednisone
National Cancer Institute (NCI)
Phase 3BB
Adriamycin
National Cancer Institute (NCI)
Phase 3BB

View all 50 →

Same molecule, other indications

Cytarabine is also rated in:

acute promyelocytic leukemiaActive
A
Indicative · Phase 4
82 / 100
View asset →
adult acute lymphoblastic leukemiaActive
BBB
Indicative · Phase 4
79 / 100
View asset →
acute myeloblastic leukemia with maturationDormant
BBB
Indicative · Phase 3
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →